Last updated: June 2, 2025
Compounded GLP-1 is a glucagon-like peptide-1 (GLP-1) receptor agonist that may be prescribed for chronic weight management and blood sugar control. Belle offers compounded GLP-1 through licensed healthcare providers when medically appropriate.
Please review the following important safety information before starting treatment. This is not a complete list of all possible risks and side effects. You should speak with your provider for personalized guidance.
In animal studies, compounded semaglutide caused thyroid C-cell tumors. It is not known if this risk occurs in humans. However, compounded semaglutide should not be used in patients with a personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Do not take compounded GLP-1 if you:
If you are breastfeeding, consult your provider before starting treatment.
Tell your provider if you have or have had:
Compounded GLP-1 slows gastric emptying, which may impact the absorption of oral medications. Your provider may adjust your medication schedule accordingly.
Compounded GLP-1 may cause the following side effects:
These side effects are usually mild to moderate and tend to decrease over time. Notify your provider if symptoms persist or become severe.
Although rare, serious side effects may include:
If you experience any of these symptoms, seek medical attention immediately.
Store compounded GLP-1 according to the instructions provided with your medication. Keep out of reach of children and dispose of any expired or unused medication safely.
Always speak with your licensed provider if you have any questions or concerns about your treatment, side effects, or medication use. Do not start or stop Semaglutide without medical supervision.